Back to Search Start Over

An episomal DNA vector platform for the persistent genetic modification of pluripotent stem cells and their differentiated progeny.

Authors :
Roig-Merino A
Urban M
Bozza M
Peterson JD
Bullen L
Büchler-Schäff M
Stäble S
van der Hoeven F
Müller-Decker K
McKay TR
Milsom MD
Harbottle RP
Source :
Stem cell reports [Stem Cell Reports] 2022 Jan 11; Vol. 17 (1), pp. 143-158. Date of Electronic Publication: 2021 Dec 22.
Publication Year :
2022

Abstract

The genetic modification of stem cells (SCs) is typically achieved using integrating vectors, whose potential integrative genotoxicity and propensity for epigenetic silencing during differentiation limit their application. The genetic modification of cells should provide sustainable levels of transgene expression, without compromising the viability of a cell or its progeny. We developed nonviral, nonintegrating, and autonomously replicating minimally sized DNA nanovectors to persistently genetically modify SCs and their differentiated progeny without causing any molecular or genetic damage. These DNA vectors are capable of efficiently modifying murine and human pluripotent SCs with minimal impact and without differentiation-mediated transgene silencing or vector loss. We demonstrate that these vectors remain episomal and provide robust and sustained transgene expression during self-renewal and targeted differentiation of SCs both in vitro and in vivo through embryogenesis and differentiation into adult tissues, without damaging their phenotypic characteristics.<br /> (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
2213-6711
Volume :
17
Issue :
1
Database :
MEDLINE
Journal :
Stem cell reports
Publication Type :
Academic Journal
Accession number :
34942088
Full Text :
https://doi.org/10.1016/j.stemcr.2021.11.011